In the most recent trading session, Zoetis (ZTS) closed at $74.81, indicating a +2.37% shift from th

Whether you want a higher 3% dividend yield or a quickly growing dividend that yields 1.2%, these tw

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYS

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Drug-resistant heartworm is a growing conc

On Thursday, Zoetis (NYSE:ZTS) discussed second-quarter financial results during its earnings call.

Rockland Trust Co. boosted its stake in Zoetis Inc. (NYSE: ZTS) by 19.8% in the third quarter, accor

Zoetis (ZTS) reached $69.1 at the closing of the latest trading day, reflecting a -1.05% change comp

Zoetis Inc. (ZTS) has fallen 71% from its 2021 peak, now trading at 2017 levels, as pricing power er

In the most recent trading session, Zoetis (ZTS) closed at $70.27, indicating a -1.87% shift from th

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast

Zoetis (ZTS) closed at $71.4 in the latest trading session, marking a -2.22% move from the prior day

Zoetis faces ongoing headwinds but is now considered a cautious 'Buy' as valuation reflects low-to-m

Zoetis NYSE: ZTS executives said the company remains confident in its previously issued guidance des

Zoetis is rated a buy, as I see current headwinds as temporary and the stock undervalued based on my

Zoetis Inc. (ZTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Corient Private Wealth LP lowered its stake in Zoetis Inc. (NYSE: ZTS) by 8.9% in the second quarter

Zoetis (NYSE: ZTS - Get Free Report) and Urogen Pharma (NASDAQ: URGN - Get Free Report) are both hea

Michael Burry, a hedge fund manager and investor known for predicting the 2008 financial crash, has

HB Wealth Management LLC increased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 190.0% during t

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced tha

Phibro Animal Health's Zoetis MFA acquisition has created a larger animal health platform with stron

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Stifel analyst Jonathan Block maintains Zoetis (NYSE:ZTS) with a Hold and lowers the price target

https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-trea

BNP Paribas analyst Navann Ty maintains Zoetis (NYSE:ZTS) with a Outperform and lowers the price

Piper Sandler analyst David Westenberg maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the

U.S. stocks close higher on Friday, with Nasdaq up 300 points and S&P 500 at record high. Benzin

UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target

JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price

Zoetis beat second-quarter earnings estimates but missed on revenue, cut 2026 guidance and cited wea

Zoetis (NYSE:ZTS) lowers FY2026 Adj EPS guidance from $6.85-$7.00 to $6.15-$6.25 vs $6.88 analyst es

Zoetis (NYSE:ZTS) reported quarterly earnings of $1.87 per share which beat the analyst consensus es

Michael Burry expands short positions against Nvidia and AI, while piling into de-risked value stock

UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target

Morgan Stanley analyst Erin Wright maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the p

Zoetis Inc. (NYSE:ZTS) today announced the commercial launch of Portela® (relfovetmab) in Canada and

The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of

July 15, 2026 records indicate that Representative Byron Donalds filed a sale of Cadence Design Syst

Zoetis Inc. today announced its agreement to acquire VitalRADS, a veterinary teleradiology services

Recombinant vector vaccine protects chickens against Newcastle disease and Marek's disease in a

Barclays analyst Glen Santangelo maintains Zoetis (NYSE:ZTS) with a Equal-Weight and lowers the p

TD Cowen analyst Steve Scala maintains Zoetis (NYSE:ZTS) with a Buy and lowers the price target f

Cramer says Zoetis has issues. Prefers this stock in animal health industry. Energy Transfer is in a

The health care sector's most oversold stocks are a buying opportunity due to undervalued compan

Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downg

Weak earnings, soft guidance and analyst target cuts triggered sharp selloffs across healthcare, sof

U.S. stocks drifted near records Thursday as oil slipped on Iran-Hormuz peace hopes. Coinbase, Airbn